ABBV Jan 2025 200.000 put
| Previous close | 55.42 |
| Open | 55.42 |
| Bid | 44.50 |
| Ask | 46.30 |
| Strike | 200.00 |
| Expiry date | 2025-01-17 |
| Day's range | 55.42 - 55.42 |
| Contract range | N/A |
| Volume | |
| Open interest | 504 |
- Motley Fool
2 Relatively Safe Dividend Stocks You Won't Regret Owning
While there's no ironclad method for picking perfectly safe stocks, thankfully there are a few dividend-paying companies that are a bit less risky than average -- as a result of their history of effective competition and their management's skill at executing their business models. Both of the stocks I'll review in a moment are likely to keep growing and paying their shareholders for a very long time, and that means you aren't likely to regret making a purchase. When it comes to appealing biopharma dividend stocks that investors can depend on, AbbVie (NYSE: ABBV) is near the top of the list.
- Motley Fool
This Is the Best Dividend ETF You Can Buy
The Schwab U.S. Dividend ETF (NYSEMKT: SCHD) just went through its annual reconstitution, meaning the top positions look different than they did just a few weeks prior. AbbVie (NYSE: ABBV) is now the fund's largest weighted position.
- Zacks
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, AbbVie (ABBV) closed at $157.54, marking a -0.3% move from the previous day.
